Theralase to Present at Noble Investor Conference
Toronto, Ontario – January 13, 2016, Theralase Technologies Inc. (“Theralase” or the “Company”) (TLT:TSXV) (TLTFF:OTC), a leading biotechnology manufacturer focused on commercializing medical technologies to eliminate pain and destroy cancer, announced today that Michael Borovec, Director of Investor Relations will present at the NobleCon12 - Noble Financial Capital Markets’ Twelfth Annual Investor Conference at Club Med in Florida, on Tuesday, January 19th at 3:00 pm EST in Room 3.
Following the Conference on January 22, 2016, a high-definition video webcast of Theralase’s presentation and a copy of the presentation materials will be available on the Company's web site www.theralase.com or as part of a complete catalog of presentations available at Noble Financial websites: www.noblefcm.com, or nobleconference.com. You will require a Microsoft SilverLight viewer (a free download from the presentation link) to participate. The webcast and presentation will be archived on the company's website and on the Noble websites for 90 days following the event.
About Noble Financial Capital Markets
Noble Financial Capital Markets established in 1984, is an equity-research driven, full-service, investment & merchant banking boutique focused on the healthcare, media & entertainment, technology and natural resources sectors. The company has offices in Boca Raton, New York, Boston and Los Angeles. In addition to the annual multi-sector NobleCon, each year Noble hosts numerous “non-deal” corporate road shows and sector-specific conferences.